Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae

被引:22
|
作者
Hayakawa, Kayoko [1 ]
Nakano, Ryuichi [2 ]
Hase, Ryota [3 ]
Shimatani, Michitsugu [4 ]
Kato, Hideaki [5 ]
Hasumi, Jumpei [6 ]
Doi, Asako [7 ]
Sekiya, Noritaka [8 ]
Nei, Takahito [9 ]
Okinaka, Keiji [10 ]
Kasahara, Kei [11 ]
Kurai, Hanako [12 ]
Nagashima, Maki [1 ]
Miyoshi-Akiyama, Tohru [13 ]
Kakuta, Risako [2 ]
Yano, Hisakazu [2 ]
Ohmagari, Norio [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan
[2] Nara Med Univ, Dept Microbiol & Infect Dis, Nara, Japan
[3] Japanese Red Cross Narita Hosp, Dept Infect Dis, Chiba, Japan
[4] Hamamatsu Med Ctr, Dept Infect Dis & Infect Control, Shizuoka, Japan
[5] Yokohama City Univ Med, Infect Prevent & Control Dept, Yokohama, Kanagawa, Japan
[6] Saku Med Ctr, Dept Pediat, Nagano, Japan
[7] Kobe City Med Ctr Gen Hosp, Div Infect Dis, Kobe, Hyogo, Japan
[8] Komagome Hosp, Dept Infect Prevent & Control, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[9] Nippon Med Coll Hosp, Dept Infect Prevent & Control, Tokyo, Japan
[10] Natl Canc Ctr Hosp East, Div Gen Internal Med, Chiba, Japan
[11] Nara Med Univ, Ctr Infect Dis, Nara, Japan
[12] Shizuoka Canc Ctr, Div Infect Dis, Shizuoka, Japan
[13] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Tokyo, Japan
关键词
ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; INACTIVATION METHOD; MULTIPLEX PCR; PREVALENCE; OUTCOMES; HEALTH; JAPAN;
D O I
10.1093/jac/dkz501
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are classified as carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE; the majority of CPE in Japan produce IMP carbapenemase. Objectives: We evaluated the clinico-epidemiological and microbiological information and effects of IMP-type carbapenemase production in CRE. Methods: Patients with isolations of CRE (MICs of meropenem >= 2mg/L, imipenem >= 2mg/L or cefmetazole >= 64mg/L) from August 2016 to March 2018 were included. Microbiological analyses and WGS were conducted and clinical parameters were compared between groups. Independent predictors for the isolation of CPE from patients were identified by logistic regression. For comparing clinical outcomes, a stabilized inverse probability weighting method was used to conduct propensity score-adjusted analysis. Results: Ninety isolates (27 CPE and 63 non-CPE) were collected from 88 patients (25 CPE and 63 non-CPE). All CPE tested positive for IMP carbapenemase. Antibiotic resistance (and the presence of resistance genes) was more frequent in the CPE group than in the non-CPE group. Independent predictors for CPE isolation were residence in a nursing home or long-term care facility, longer prior length of hospital stay (LOS), use of a urinary catheter and/or nasogastric tube, dependent functional status and exposure to carbapenem. Although in-hospital and 30 day mortality rates were similar between the two groups, LOS after CRE isolation was longer in the CPE group. Conclusions: IMP-CPE were associated with prolonged hospital stays and had different clinical and microbiological characteristics compared with non-CPE. Tailored approaches are necessary for the investigational and public health reporting, and clinical and infection prevention perspectives for IMP-CPE and non-CPE.
引用
收藏
页码:697 / 708
页数:12
相关论文
共 50 条
  • [41] Hazard Ratios and Hazardous Carbapenemase-Producing Enterobacteriaceae
    Corona, Alberto
    De Santis, Vincenzo
    Singer, Mervyn
    CRITICAL CARE MEDICINE, 2015, 43 (11) : E536 - E537
  • [42] Treating infections caused by carbapenemase-producing Enterobacteriaceae
    Tzouvelekis, L. S.
    Markogiannakis, A.
    Piperaki, E.
    Souli, M.
    Daikos, G. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (09) : 862 - 872
  • [43] Carbapenemase-Producing Enterobacteriaceae in Yunnan Province, China
    Zheng Rui
    Liu Dehua
    Niu Hua
    Feng Yue
    Xu Yunmin
    Li Jianhua
    Xia Xueshan
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2016, 69 (06) : 528 - 530
  • [44] Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
    Kopotsa, Katlego
    Sekyere, John Osei
    Mbelle, Nontombi Marylucy
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1457 (01) : 61 - 91
  • [45] Evaluation of the Carbapenem Detection Set™ for the detection and characterization of carbapenemase-producing Enterobacteriaceae
    Dortet, Laurent
    Bernabeu, Sandrine
    Gonzalez, Camille
    Naas, Thierry
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (03) : 220 - 225
  • [47] Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae
    Dortet, Laurent
    Cuzon, Gaelle
    Plesiat, Patrick
    Naas, Thierry
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 135 - 140
  • [48] Carbapenemase-producing Enterobacteriaceae in animals and methodologies for their detection
    Anderson, Rebecca E., V
    Boerlin, Patrick
    CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2020, 84 (01): : 3 - 17
  • [49] Carbapenemase-producing Enterobacteriaceae surveillance in Malaysian hospitals
    Norazah, A.
    Suraya, A.
    Farah, B. Nor
    Surianti, S.
    Rohaidah, H.
    Rohana, O.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S102 - S103
  • [50] In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
    Poirel, Laurent
    Kieffer, Nicolas
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 156 - 161